Arcus Biosciences, Inc. (RCUS)
NYSE·Healthcare·Biotechnology
$26.22
-2.34%
Mkt Cap $3.38B
Analyst Ratings
Buy
5
Hold
2
Sell
0
Price Target (24 analysts)
$31.75
Range $22.00 – $47.00
Implied Upside
+21.1%
Consensus $31.75 vs current $26.22
NYSE·Healthcare·Biotechnology
$26.22
-2.34%
Mkt Cap $3.38B
Buy
5
Hold
2
Sell
0
Price Target (24 analysts)
$31.75
Range $22.00 – $47.00
+21.1%
Consensus $31.75 vs current $26.22